NCT04742959 2024-04-26
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
Phase 1/2 Completed
TransThera Sciences (Nanjing), Inc.
Big Ten Cancer Research Consortium
AstraZeneca
TG Therapeutics, Inc.